An analysis of the intended use of atypical antipsychotics in dementia

Psychiatry (Edgemont)

Volumn 7, Issue 11, 2010, Pages 14-17

  Ventimiglia, Jeff ^a   Kalali, Amir H ^b   Vahia, Ipsit V ^c   Jeste, Dilip V ^c  

^a IQVIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atypical antipsychotic; Dementia; FDA warning; Psychiatric; Risk management

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT;

ARTICLE; CONTROLLED STUDY; DEMENTIA; DRUG INDICATION; DRUG INFORMATION; DRUG MARKETING; DRUG SAFETY; DRUG USE; PHYSICIAN ATTITUDE; PRESCRIPTION; TREND STUDY;

EID: 78650039198     PISSN: 15505952     EISSN: 15555194     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Lyketsos CG, Steinberg M, Tschanz JT, et al. Mental and behavioral disturbances in dementia: findings from the Cache County Study on memory in aging. Am J Psychiatry. 2000;157:708-714.
2. Testad I, Aasland AM, Aarsland D. Prevalence and correlates of disruptive behavior in patients in Norwegian nursing homes. Int J Geriatr Psychiatry. 2007;22:916-921.
3. Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med. 2006;355:1525-1538.
4. Jeste DV, Blazer D, Casey DE, et al. ACNP White Paper: Update on the use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology. 2008;33:957-970
5. Jeste DV, Finkel SI. Psychosis of Alzheimer's disease and related dementias: diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry. 2000;8:29-34.
6. Salzman C, Jeste DV, Meyer RE, et al: Elderly patients with dementiarelated symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. J Clin Psychiatry. 2008;69:889-898.
7. Vernooij-Dassen M, Vasse E, Zuidema S, et al. Psychosocial interventions for dementia patients in long-term care. Int Psychogeriatr. 2010;22:1121-1128.